ENBIO Co., Ltd. (KOSDAQ:352940)
South Korea · Delayed Price · Currency is KRW 2,025.00
-55.00 (-2.64%)
At close: Aug 24, 2026
ENBIO Market Cap
ENBIO has a market cap or net worth of 22.01 billion as of August 24, 2026. Its market cap has decreased by -12.15% in one year.
Market Cap
22.01B
Enterprise Value
41.79B
Revenue
36.18B
Ranking
n/a
PE Ratio
38.32
Stock Price
2,025.00
ChartMarket Cap Chart
Since December 11, 2020, ENBIO's market cap has decreased from 123.03B to 22.01B, a decrease of -82.11%. That is a compound annual growth rate of -26.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 22.01B | -10.99% |
| Dec 30, 2025 | 24.72B | 12.62% |
| Dec 30, 2024 | 21.95B | -42.37% |
| Dec 28, 2023 | 38.09B | -17.82% |
| Dec 29, 2022 | 46.35B | -46.35% |
| Dec 30, 2021 | 86.40B | -45.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| C&R Research | 22.24B |
| Poongjeon Pharmacy CO.,LTD. | 22.19B |
| Dasan Solueta | 22.18B |
| AztechWB | 22.15B |
| Studio Samick | 22.06B |
| OA Co., Ltd. | 22.06B |
| Deep Commerce | 21.87B |
| EXA E&C | 21.76B |